Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.88B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B |
Gross Profit | 19.10B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B |
EBITDA | 5.58B | 5.93B | 4.00B | 3.72B | 4.74B | 3.82B |
Net Income | 3.97B | 4.07B | 2.87B | 3.73B | 3.26B | 3.08B |
Balance Sheet | ||||||
Total Assets | 804.14B | 802.16B | 713.23B | 701.46B | 630.49B | 600.49B |
Cash, Cash Equivalents and Short-Term Investments | 25.99B | 24.71B | 19.38B | 18.84B | 17.23B | 7.95B |
Total Debt | 9.54B | 10.23B | 9.65B | 11.29B | 9.73B | 10.71B |
Total Liabilities | 771.05B | 771.01B | 683.38B | 669.14B | 600.00B | 573.48B |
Stockholders Equity | 29.91B | 29.54B | 26.84B | 29.01B | 27.22B | 24.03B |
Cash Flow | ||||||
Free Cash Flow | 4.33B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B |
Operating Cash Flow | 4.33B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B |
Investing Cash Flow | -196.00M | -408.00M | -786.00M | -5.49B | -11.21B | -8.20B |
Financing Cash Flow | -2.44B | -2.29B | -3.55B | -620.00M | -992.00M | 2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | C$50.09B | 13.53 | 14.19% | 4.30% | 15.27% | 4.72% | |
67 Neutral | $17.03B | 11.50 | 9.79% | 3.95% | 10.63% | 1.98% | |
― | $53.58B | 13.88 | 11.57% | 4.00% | ― | ― | |
― | $34.93B | 15.65 | 13.18% | 3.93% | ― | ― | |
― | $42.06B | 8.29 | 18.70% | 0.86% | ― | ― | |
75 Outperform | C$13.17B | 13.16 | 13.43% | 2.47% | -4.55% | 42.41% | |
71 Outperform | C$36.29B | 13.48 | 11.92% | 5.24% | 7.63% | 8.84% |
Great-West Lifeco Inc. reported record base earnings of over $1.1 billion for Q2 2025, marking an 11% increase from the previous year, driven by strong performance in its wealth and group benefits businesses. Despite a decline in net earnings due to business transformation charges and market challenges, the company plans an additional $500 million in share buybacks, reflecting its strong capital position and focus on growth strategies.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced that its President and CEO, David Harney, will participate in a virtual fireside chat with CIBC Capital Markets to discuss the company’s second quarter 2025 financial results. This event signifies the company’s commitment to transparency and engagement with stakeholders, potentially impacting its market perception and investor relations.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Investment Planning Counsel Inc. (IPC), a subsidiary of Canada Life, has announced its acquisition of the wealth assets of De Thomas Wealth Management Corp. This strategic move aims to reinforce IPC’s vision of becoming a leading destination for entrepreneurial advisors by providing enhanced tools, platforms, and support. The acquisition is expected to foster deeper relationships between advisors and clients, allowing for business growth and value capture. The transaction, anticipated to complete by the end of Q3 2025, will enable De Thomas advisors to maintain their independence while benefiting from IPC’s resources, marking a collaborative effort that honors the strengths and legacy of both organizations.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. will release its second quarter 2025 financial results on August 5, 2025, with a subsequent earnings conference call scheduled for August 6. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, impacting its market positioning and investor relations.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Canada Life Reinsurance, a subsidiary of Great-West Lifeco, announced a strategic shift by ceasing new business for its U.S. traditional life mortality risk reinsurance line to focus more on structured reinsurance markets. This decision aims to allocate more resources to structured solutions, longevity reinsurance, and catastrophe retrocession, while ensuring a smooth transition for existing clients and maintaining high service levels for its inforce business.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco has appointed Lindsey Rix-Broom as CEO of its European operations, effective July 1, 2025. Rix-Broom, who currently leads Canada Life U.K., is recognized for her leadership and strategic focus, having driven significant growth and modernization in the U.K. market. Her appointment is part of a broader leadership transition, with David Harney taking over as President & CEO of Great-West Lifeco and Canada Life. This strategic move aims to strengthen Lifeco’s presence in Europe, particularly in the U.K., Ireland, and Germany, as the company continues to focus on delivering sustainable growth and value.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced the election of all 19 director nominees during its Annual and Special Meeting of Shareholders. The election results showed strong support for the nominees, indicating stability and continuity in the company’s governance. This decision is expected to reinforce Great-West Lifeco’s strategic direction and maintain its robust position in the financial services industry, benefiting stakeholders by ensuring consistent leadership.
Great-West Lifeco reported strong first quarter 2025 results, with base earnings of $1.0 billion, marking a 5% increase from the previous year, driven by growth in its Retirement and Wealth businesses. Despite a 17% decline in net earnings from continuing operations due to unfavorable market conditions, the company maintained a robust capital position with a LICAT ratio of 130% and continued its strategic focus on capital-efficient growth, particularly in the U.S. segment, which contributed significantly to its performance.